-
Mashup Score: 14ClinicalTrials.gov - 11 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 44ClinicalTrials.gov - 11 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
LYSA trial: first investigator-led study supported by @UCCCancerTrials @hrbireland infrastructure https://t.co/zpBMRxYY8C Funded @IrishCancerSoc @BreakthroCancer Enabled by amazing team @CUH_Cork @UCC @uniofgalway and PPI team Thank you!! #TeamScience https://t.co/yWo18hRzaf
-
-
Mashup Score: 8ClinicalTrials.gov - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
First: Trials in progress Poster on our IIT testing MEK, STAT3 and PD1 inhibition in metastatic pancreas cancer https://t.co/aMTGb1ziVW https://t.co/kEjy4NKYf3
-
-
Mashup Score: 2CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Expert PicksTweet-
RT @ljlaffin: @DrMarthaGulati @RawanAAmir Lilly is with SURMOUNT MMO (https://t.co/reCZA846XX) it's tirzepatide's CVOT. Not strictly primar…
-
-
Mashup Score: 10CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Onc News and JournalsTweet-
Just activated: @SWOG S2213: Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL #Amyloidosis. Visit the @theCTSU website or https://t.co/RDypkYRixE
-
-
Mashup Score: 38CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
We have already enrolled 55 patients in 6 months on this study evaluating serial #PSMA #imaging in #BCR #ProstateCancer @theNCI Appreciate the support of referring docs who have sent us patients already & patients who have reached out Lots to learn https://t.co/d1vz4ahTTs https://t.co/AJpVGShGfG
-
-
Mashup Score: 0CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
https://t.co/bxL4vmfMtw
-
-
Mashup Score: 0CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: Cardiologists, Latest HeadlinesTweet-
https://t.co/j57cRU43Un
-
-
Mashup Score: 0CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP, or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With #DLBCL https://t.co/COM7w5krFu
-
-
Mashup Score: 0CTG Labs - NCBI - 1 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: www.clinicaltrials.govCategories: Cardiologists, Latest HeadlinesTweet-
#TCT2023 More about #microvasculardysfunction @TCTConference @HashimHayder 👇 is leading these efforts @MedStarWHC and also is launching #CMD registry https://t.co/eD3O7H5boe If you want to participate, please text us! Can #CMD be measured by #angio👇 https://t.co/kWCUnSyyx6… https://t.co/gKpjgX7RUP https://t.co/UESFyqrQmH
-
Imp. article on "less is more" approaches in #myeloma. An ongoing "less is more" trial that I love is @AlGarfall's LimiTEC trial [https://t.co/VZqZFC1TjW], that will generate prospective data on fixed-duration [6-9 months] teclistamab. Glad to be a subsite for the trial! #mmsm https://t.co/PwibtI7DjM https://t.co/Q1qyBktWzK